Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rockland Immunochemicals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7549
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-Plus, blood products, GFP Antibodies, blocking buffers, proteins and peptides, fluorescent TrueBlot, phospho-specific, and melanoma cell lines, among others. It offers services such as custom peptide services, antibody purification, custom antibody production, cell culture services, custom assay development, antibody fragmentation and generation, custom conjugations, IHC studies and IVD service solutions. Rockland produces antibodies and antibody-based tools used to help mechanisms underlying cell function and disease. The company markets its products through distributors in the US, Austria, Belgium, Australia, Brazil, Canada, Chile and Denmark among others. Rockland is headquartered in Limerick, Pennsylvania, the US.

Rockland Immunochemicals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Rockland Immunochemicals Acquires Epi-Plus Product Line From Twentyfirst Century Biochemicals 11
Partnerships 12
Formula Pharma Enters into Co-Development Agreement with Rockland Immunochemicals 12
Rockland Immunochemicals Enters Into Co-Development Agreement With National Cancer Institute 13
Licensing Agreements 14
Rockland Immunochemicals Expands Licensing Agreement With LIMR Development 14
Rockland Immunochemicals Enters Into Licensing Agreement With LIMR Development 15
Rockland Immunochemicals Inc – Key Competitors 16
Rockland Immunochemicals Inc – Key Employees 17
Rockland Immunochemicals Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rockland Immunochemicals Acquires Epi-Plus Product Line From Twentyfirst Century Biochemicals 11
Formula Pharma Enters into Co-Development Agreement with Rockland Immunochemicals 12
Rockland Immunochemicals Enters Into Co-Development Agreement With National Cancer Institute 13
Rockland Immunochemicals Expands Licensing Agreement With LIMR Development 14
Rockland Immunochemicals Enters Into Licensing Agreement With LIMR Development 15
Rockland Immunochemicals Inc, Key Competitors 16
Rockland Immunochemicals Inc, Key Employees 17

List of Figures
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SkinMedica Inc-製薬・医療分野:企業M&A・提携分析
    Summary SkinMedica Inc (SkinMedica) is a manufacturer and distributor of skin care products. The company’s products include purifying foaming wash, facial cleanser, skin polisher, purifying toner, TNS recovery complex, uplifting eye serum, restorative ointment, dermal repair cream, and post procedur …
  • Ra Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • STRATA Skin Sciences Inc (SSKN):医療機器:M&Aディール及び事業提携情報
    Summary STRATA Skin Sciences Inc (STRATA) is a seller of therapeutic and aesthetic dermatology products. Its product portfolio comprises XTRAC laser and VTRAC excimer lamp; the STRATAPEN MicroSystems; and Nordlys. XTRAC laser and VTRAC excimer lamp systems are utilized for the treatment of psoriasis …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • OMV Petrom SA (SNP):石油・ガス:M&Aディール及び事業提携情報
    Summary OMV Petrom SA (Petrom), a subsidiary of OMV AG, is an integrated energy company that explores for, develops and produces crude oil and natural gas. The company processes and refines crude oil and sells refined products. It conducts power generation and has considerable wind energy operations …
  • Bioquell Ltd:企業の戦略的SWOT分析
    Bioquell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hyundai Steel Co:戦略・SWOT・企業財務分析
    Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Pandora Media, Inc.:企業のM&A・事業提携・投資動向
    Pandora Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pandora Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Theranostics Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Erin Energy Corp (ERN):企業の財務・戦略的SWOT分析
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Unipetrol AS (UNIPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Unipetrol AS (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carries …
  • Aeon Global Health Corp (ADAT):医療機器:M&Aディール及び事業提携情報
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp, is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆